FDA Inspection 813447 — Velocity Pharma LLC

Velocity Pharma LLC — FEI 2000044401

The FDA completed an inspection of Velocity Pharma LLC on January 11, 2013 in Melville, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 11, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melville, NY (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
163321 CFR 211.130(d)Examination of packaging and labeling
191421 CFR 211.166(a)Lack of written stability program
241921 CFR 211.198(a)Complaint Handling Procedure
433821 CFR 211.150(b)Recall facilitation
434221 CFR 211.142(b)Storage under appropriate conditions
439921 CFR 211.186(b)(7)Theoretical yield statement including percentages